{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:48:19Z","timestamp":1779889699129,"version":"3.53.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008751","name":"Bundesinstitut f\u00fcr Risikobewertung","doi-asserted-by":"publisher","award":["1322-824"],"award-info":[{"award-number":["1322-824"]}],"id":[{"id":"10.13039\/501100008751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bundesinstitut f\u00fcr Risikobewertung (BfR)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>1,2-Unsaturated pyrrolizidine alkaloids (PA) induce severe acute and chronic hepatotoxicity. Effects include an impairment of the cell cycle. To elucidate this effect, cell cycle progression was analyzed by flow cytometry, changes in cell and nucleus size, differential gene expression and protein phosphorylation patterns of regulatory key proteins in the Chinese hamster lung fibroblast cell line V79 and\/or the human hepatoblastoma cell line HepG2, both overexpressing human CYP3A4 (V79<jats:sub>3A4<\/jats:sub>\/HepG2<jats:sub>3A4<\/jats:sub>). Lasiocarpine, a potent PA representative, reduced the cell viability of human CYP3A4-overexpressing cell lines concentration-dependently. Microscopic observation showed a marked increase in cell and nucleus size of V79<jats:sub>3A4<\/jats:sub> cells after exposure to 10 \u00b5M lasiocarpine. In the human CYP3A4-overexpressing cell lines, cells accumulate in G<jats:sub>2<\/jats:sub>\/M phase after lasiocarpine treatment. Based on these findings, the gene expression pattern of cell cycle-related genes was investigated in HepG2<jats:sub>3A4<\/jats:sub> cells showing a decrease of e. g. <jats:italic>WEE1<\/jats:italic>, and <jats:italic>CHEK1<\/jats:italic> and an increase of <jats:italic>PAK1<\/jats:italic> and <jats:italic>ATM<\/jats:italic>. While results on cell cycle regulation at the level of gene expression are of limited relevance, protein phosphorylation plays an important role. Therefore, we also elucidated the protein phosphorylation status of regulatory key proteins. The results clearly indicate an induction of the DNA damage response and a late G2 arrest. In conclusion, an impairment of the cell cycle was observed. It correlates with the metabolic activation of lasiocarpine and is most likely mediated by adduct formation of the reactive pyrrole esters with DNA, leading to a disruption of cellular homeostasis and genomic instability.<\/jats:p>","DOI":"10.1007\/s00204-025-04185-y","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:25:55Z","timestamp":1758000355000},"page":"4955-4971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The pyrrolizidine alkaloid lasiocarpine impairs cell cycle progression in vitro"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-0035","authenticated-orcid":false,"given":"Stefanie","family":"Hessel-Pras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Beckschulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Koellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Rosskopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Templin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Sprenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Boehmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Heiner","family":"Kuepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Sachse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"issue":"2","key":"4185_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10565-021-09599-9","volume":"38","author":"S Abdelfatah","year":"2022","unstructured":"Abdelfatah S, Na\u00df J, Knorz C, Klauck SM, K\u00fcpper JH, Efferth T (2022) Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells. Cell Biol Toxicol 38(2):325\u2013345. https:\/\/doi.org\/10.1007\/s10565-021-09599-9","journal-title":"Cell Biol Toxicol"},{"key":"4185_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101475","author":"S Al Bitar","year":"2019","unstructured":"Al Bitar S, Gali-Muhtasib H (2019) The role of the cyclin dependent kinase inhibitor p21(cip1\/waf1) in targeting cancer: molecular mechanisms and novel therapeutics. Cancers. https:\/\/doi.org\/10.3390\/cancers11101475","journal-title":"Cancers"},{"key":"4185_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.fct.2018.08.003","volume":"121","author":"A Allemang","year":"2018","unstructured":"Allemang A, Mahony C, Lester C, Pfuhler S (2018) Relative potency of fifteen pyrrolizidine alkaloids to induce DNA damage as measured by micronucleus induction in HepaRG human liver cells. Food Chem Toxicol 121:72\u201381. https:\/\/doi.org\/10.1016\/j.fct.2018.08.003","journal-title":"Food Chem Toxicol"},{"issue":"Suppl 2","key":"4185_CR4","first-page":"9","volume":"50","author":"A Bane","year":"2012","unstructured":"Bane A, Seboxa T, Mesfin G et al (2012) An outbreak of veno-occlusive liver disease in northern Ethiopia, clinical findings. Ethiop Med J 50(Suppl 2):9\u201316","journal-title":"Ethiop Med J"},{"issue":"19","key":"4185_CR5","first-page":"189","volume":"5","author":"YA Bick","year":"1972","unstructured":"Bick YA, Brown JK (1972) An analysis of chromosomal sensitivity of HPK1 cells from the marsupial Potorous tridactylus to x-rays and to heliotrine. Cytobios 5(19):189\u2013200","journal-title":"Cytobios"},{"issue":"3","key":"4185_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1071\/bi9680469","volume":"21","author":"YA Bick","year":"1968","unstructured":"Bick YA, Jackson WD (1968) Effects of the pyrrolizidine alkaloid heliotrine on cell division and chromosome breakage in cultures of leucocytes from the marsupial Potorous tridactylus. Aust J Biol Sci 21(3):469\u2013481. https:\/\/doi.org\/10.1071\/bi9680469","journal-title":"Aust J Biol Sci"},{"issue":"5","key":"4185_CR7","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nrc3711","volume":"14","author":"KT Bieging","year":"2014","unstructured":"Bieging KT, Mello SS, Attardi LD (2014) Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14(5):359\u2013370. https:\/\/doi.org\/10.1038\/nrc3711","journal-title":"Nat Rev Cancer"},{"key":"4185_CR8","first-page":"239","volume-title":"Veterinary toxicology 3rd ed","author":"K Bischoff","year":"2018","unstructured":"Bischoff K, Mukai M, Ramaiah SK (2018) Chapter 15 - liver toxicity. In: Gupta RC (ed) Veterinary toxicology 3rd ed. Academic Press, pp 239\u2013257"},{"key":"4185_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113049","volume":"164","author":"J Buchmueller","year":"2022","unstructured":"Buchmueller J, Enge AM, Peters A et al (2022) The chemical structure impairs the intensity of genotoxic effects promoted by 1,2-unsaturated pyrrolizidine alkaloids in vitro. Food Chem Toxicol 164:113049. https:\/\/doi.org\/10.1016\/j.fct.2022.113049","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"4185_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcp.25048","volume":"231","author":"WJ Cannan","year":"2016","unstructured":"Cannan WJ, Pederson DS (2016) Mechanisms and consequences of double-strand DNA break formation in chromatin. J Cell Physiol 231(1):3\u201314. https:\/\/doi.org\/10.1002\/jcp.25048","journal-title":"J Cell Physiol"},{"key":"4185_CR11","first-page":"1","volume":"27","author":"P Chan","year":"1993","unstructured":"Chan P (1993) NTP technical report on the toxicity studies of Riddelliine (CAS no. 23246-96-0) administered by gavage to F344 rats and B6C3F1 mice. Tox Rep Ser 27:1-d9","journal-title":"Tox Rep Ser"},{"issue":"5","key":"4185_CR12","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/nar\/25.5.992","volume":"25","author":"W Chaung","year":"1997","unstructured":"Chaung W, Mi LJ, Boorstein RJ (1997) The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair. Nucleic Acids Res 25(5):992\u2013994. https:\/\/doi.org\/10.1093\/nar\/25.5.992","journal-title":"Nucleic Acids Res"},{"key":"4185_CR13","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2994","author":"G Chen","year":"2018","unstructured":"Chen G, Deng X (2018) Cell Synchronization by Double Thymidine Block. Bio Protoc. https:\/\/doi.org\/10.21769\/BioProtoc.2994","journal-title":"Bio Protoc"},{"issue":"3","key":"4185_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/jat.1504","volume":"30","author":"T Chen","year":"2010","unstructured":"Chen T, Mei N, Fu PP (2010) Genotoxicity of pyrrolizidine alkaloids. J Appl Toxicol 30(3):183\u2013196. https:\/\/doi.org\/10.1002\/jat.1504","journal-title":"J Appl Toxicol"},{"key":"4185_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.fct.2019.05.019","volume":"130","author":"J Ebmeyer","year":"2019","unstructured":"Ebmeyer J, Braeuning A, Glatt H, These A, Hessel-Pras S, Lampen A (2019) Human CYP3A4-mediated toxification of the pyrrolizidine alkaloid lasiocarpine. Food Chem Toxicol 130:79\u201388. https:\/\/doi.org\/10.1016\/j.fct.2019.05.019","journal-title":"Food Chem Toxicol"},{"issue":"11","key":"4185_CR16","first-page":"2406","volume":"9","author":"EFSA","year":"2011","unstructured":"EFSA (2011) Scientific Opinion on Pyrrolizidine alkaloids in food and feed - EFSA Panel on Contaminants in the Food Chain (CONTAM). EFSA J 9(11):2406\u20132540","journal-title":"EFSA J"},{"issue":"7","key":"4185_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2903\/j.efsa.2017.4908","volume":"15","author":"EFSA","year":"2017","unstructured":"EFSA (2017) Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements. EFSA J 15(7):34. https:\/\/doi.org\/10.2903\/j.efsa.2017.4908","journal-title":"EFSA J"},{"key":"4185_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/plants8030054","author":"J Flade","year":"2019","unstructured":"Flade J, Beschow H, Wensch-Dorendorf M, Plescher A, W\u00e4tjen W (2019) Occurrence of nine pyrrolizidine alkaloids in Senecio vulgaris L. depending on developmental stage and season. Plants. https:\/\/doi.org\/10.3390\/plants8030054","journal-title":"Plants"},{"issue":"1","key":"4185_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/DMR-120028426","volume":"36","author":"PP Fu","year":"2004","unstructured":"Fu PP, Xia Q, Lin G, Chou MW (2004) Pyrrolizidine alkaloids\u2014genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 36(1):1\u201355. https:\/\/doi.org\/10.1081\/DMR-120028426","journal-title":"Drug Metab Rev"},{"key":"4185_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010202","author":"J Gl\u00fcck","year":"2020","unstructured":"Gl\u00fcck J, Waizenegger J, Braeuning A, Hessel-Pras S (2020) Pyrrolizidine alkaloids induce cell death in human HepaRG cells in a structure-dependent manner. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22010202","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4185_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","volume":"20","author":"A Hafner","year":"2019","unstructured":"Hafner A, Bulyk ML, Jambhekar A, Lahav G (2019) The multiple mechanisms that regulate p53 activity and cell fate. Nat Rev Mol Cell Biol 20(4):199\u2013210. https:\/\/doi.org\/10.1038\/s41580-019-0110-x","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"4185_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1091\/mbc.6.4.387","volume":"6","author":"JW Harper","year":"1995","unstructured":"Harper JW, Elledge SJ, Keyomarsi K et al (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6(4):387\u2013400. https:\/\/doi.org\/10.1091\/mbc.6.4.387","journal-title":"Mol Biol Cell"},{"issue":"4930","key":"4185_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1126\/science.2683079","volume":"246","author":"LH Hartwell","year":"1989","unstructured":"Hartwell LH, Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events. Sci 246(4930):629\u2013634. https:\/\/doi.org\/10.1126\/science.2683079","journal-title":"Sci"},{"key":"4185_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JCB-15002","volume":"1","author":"N Herzog","year":"2015","unstructured":"Herzog N, Katzenberger N, Martin F, Schmidtke KU, K JH (2015) Generation of cytochrome P450 3A4-overexpressing HepG2 cell clones for standardization of hepatocellular testosterone 6\u03b2-hydroxylation activity. J Cell Biotechnol 1:15\u201326. https:\/\/doi.org\/10.3233\/JCB-15002","journal-title":"J Cell Biotechnol"},{"issue":"1","key":"4185_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00204-019-02582-8","volume":"94","author":"S Hessel-Pras","year":"2020","unstructured":"Hessel-Pras S, Braeuning A, Guenther G et al (2020) The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Arch Toxicol 94(1):219\u2013229. https:\/\/doi.org\/10.1007\/s00204-019-02582-8","journal-title":"Arch Toxicol"},{"issue":"1","key":"4185_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0041-008x(91)90137-4","volume":"111","author":"JR Hincks","year":"1991","unstructured":"Hincks JR, Kim HY, Segall HJ, Molyneux RJ, Stermitz FR, Coulombe RA Jr (1991) DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure-activity relationships. Toxicol Appl Pharmacol 111(1):90\u201398. https:\/\/doi.org\/10.1016\/0041-008x(91)90137-4","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"4185_CR27","first-page":"405","volume":"56","author":"MV Jago","year":"1969","unstructured":"Jago MV (1969) The development of the hepatic megalocytosis of chronic pyrrolizidine alkaloid poisoning. Am J Pathol 56(3):405\u2013421","journal-title":"Am J Pathol"},{"key":"4185_CR28","unstructured":"JECFA (2020) Safety evaluation of certain food additives and contaminants: prepared by the eightieth meeting of the Joint FAO\/WHO expert Committee on food Additives (JECFA). Supplement 2: Pyrrolizidine alkaloids. WHO Food Additives Series, 71-S2"},{"key":"4185_CR29","doi-asserted-by":"publisher","first-page":"313280","DOI":"10.1155\/2010\/313280","volume":"2010","author":"F Kakar","year":"2010","unstructured":"Kakar F, Akbarian Z, Leslie T et al (2010) An outbreak of hepatic veno-occlusive disease in Western afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J Toxicol 2010:313280. https:\/\/doi.org\/10.1155\/2010\/313280","journal-title":"J Toxicol"},{"issue":"1","key":"4185_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1006\/taap.1993.1172","volume":"122","author":"HY Kim","year":"1993","unstructured":"Kim HY, Stermitz FR, Molyneux RJ, Wilson DW, Taylor D, Coulombe RA (1993) Structural influences on pyrrolizidine alkaloid-induced cytopathology. Toxicol Appl Pharmacol 122(1):61\u201369. https:\/\/doi.org\/10.1006\/taap.1993.1172","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"4185_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"4185_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.05.040","volume":"131","author":"J Louisse","year":"2019","unstructured":"Louisse J, Rijkers D, Stoopen G et al (2019) Determination of genotoxic potencies of pyrrolizidine alkaloids in HepaRG cells using the gammaH2AX assay. Food Chem Toxicol 131:110532. https:\/\/doi.org\/10.1016\/j.fct.2019.05.040","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"4185_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0009-2797(80)90055-1","volume":"30","author":"AR Mattocks","year":"1980","unstructured":"Mattocks AR, Legg RF (1980) Antimitotic activity of dehydroretronecine, a pyrrolizidine alkaloid metabolite, and some analogous compounds, in a rat liver parenchymal cell line. Chem Biol Interact 30(3):325\u2013336. https:\/\/doi.org\/10.1016\/0009-2797(80)90055-1","journal-title":"Chem Biol Interact"},{"issue":"9","key":"4185_CR34","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1136\/jcp.29.9.788","volume":"29","author":"J McGee","year":"1976","unstructured":"McGee J, Patrick RS, Wood CB, Blumgart LH (1976) A case of veno-occlusive disease of the liver in Britain associated with herbal tea consumption. J Clin Pathol 29(9):788\u2013794. https:\/\/doi.org\/10.1136\/jcp.29.9.788","journal-title":"J Clin Pathol"},{"issue":"7980","key":"4185_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0140-6736(76)90726-1","volume":"2","author":"O Mohabbat","year":"1976","unstructured":"Mohabbat O, Younos MS, Merzad AA, Srivastava RN, Sediq GG, Aram GN (1976) An outbreak of hepatic veno-occlusive disease in north-western Afghanistan. Lancet 2(7980):269\u2013271","journal-title":"Lancet"},{"issue":"1","key":"4185_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0378-1119(99)00487-4","volume":"242","author":"J Momand","year":"2000","unstructured":"Momand J, Wu H-H, Dasgupta G (2000) MDM2\u2014master regulator of the p53 tumor suppressor protein. Gene 242(1):15\u201329. https:\/\/doi.org\/10.1016\/S0378-1119(99)00487-4","journal-title":"Gene"},{"key":"4185_CR37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.cellbio.13.1.261","volume":"13","author":"DO Morgan","year":"1997","unstructured":"Morgan DO (1997) Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13:261\u2013291. https:\/\/doi.org\/10.1146\/annurev.cellbio.13.1.261","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4185_CR38","first-page":"1","volume":"508","author":"NTP","year":"2003","unstructured":"NTP (2003) Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344\/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 508:1\u2013280","journal-title":"Natl Toxicol Program Tech Rep Ser"},{"issue":"22","key":"4185_CR39","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1016\/j.febslet.2012.09.048","volume":"586","author":"N Okita","year":"2012","unstructured":"Okita N, Minato S, Ohmi E, Tanuma S, Higami Y (2012) DNA damage-induced CHK1 autophosphorylation at Ser296 is regulated by an intramolecular mechanism. FEBS Lett 586(22):3974\u20133979. https:\/\/doi.org\/10.1016\/j.febslet.2012.09.048","journal-title":"FEBS Lett"},{"issue":"1","key":"4185_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02080-z","volume":"10","author":"I Pellarin","year":"2025","unstructured":"Pellarin I, Dall\u2019Acqua A, Favero A et al (2025) Cyclin-dependent protein kinases and cell cycle regulation in biology and disease. Signal Transduct Target Ther 10(1):11. https:\/\/doi.org\/10.1038\/s41392-024-02080-z","journal-title":"Signal Transduct Target Ther"},{"issue":"1\u20132","key":"4185_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1383-5742(99)00010-1","volume":"443","author":"AS Prakash","year":"1999","unstructured":"Prakash AS, Pereira TN, Reilly PEB, Seawright AA (1999) Pyrrolizidine alkaloids in human diet. Mutat Res\/genet Toxicol Environ Mutagenesis 443(1\u20132):53\u201367. https:\/\/doi.org\/10.1016\/S1383-5742(99)00010-1","journal-title":"Mutat Res\/genet Toxicol Environ Mutagenesis"},{"issue":"1","key":"4185_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1039\/c5np00076a","volume":"34","author":"J Robertson","year":"2017","unstructured":"Robertson J, Stevens K (2017) Pyrrolizidine alkaloids: occurrence, biology, and chemical synthesis. Nat Prod Rep 34(1):62\u201389. https:\/\/doi.org\/10.1039\/c5np00076a","journal-title":"Nat Prod Rep"},{"issue":"12","key":"4185_CR43","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1007\/s00204-020-02895-z","volume":"94","author":"L Rutz","year":"2020","unstructured":"Rutz L, Gao L, K\u00fcpper JH, Schrenk D (2020) Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cells. Arch Toxicol 94(12):4159\u20134172. https:\/\/doi.org\/10.1007\/s00204-020-02895-z","journal-title":"Arch Toxicol"},{"issue":"2","key":"4185_CR44","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2144\/03342mt01","volume":"34","author":"AI Saeed","year":"2003","unstructured":"Saeed AI, Sharov V, White J et al (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34(2):374\u2013378. https:\/\/doi.org\/10.2144\/03342mt01","journal-title":"Biotechniques"},{"issue":"3","key":"4185_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0009-2797(75)90112-X","volume":"10","author":"A Samuel","year":"1975","unstructured":"Samuel A, Jago MV (1975) Localization in the cell cycle of the antimitotic action of the pyrrolizidine alkaloid, lasiocarpine and of its metabolite, dehydroheliotridine. Chem Biol Interact 10(3):185\u2013197. https:\/\/doi.org\/10.1016\/0009-2797(75)90112-X","journal-title":"Chem Biol Interact"},{"issue":"10","key":"4185_CR46","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.18632\/oncotarget.1861","volume":"5","author":"M Sanhaji","year":"2014","unstructured":"Sanhaji M, Ritter A, Belsham HR et al (2014) Polo-like kinase 1 regulates the stability of the mitotic centromere-associated kinesin in mitosis. Oncotarget 5(10):3130\u20133144. https:\/\/doi.org\/10.18632\/oncotarget.1861","journal-title":"Oncotarget"},{"issue":"2","key":"4185_CR47","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1006\/abbi.1996.0345","volume":"332","author":"A Schneider","year":"1996","unstructured":"Schneider A, Schmalix WA, Siruguri V et al (1996) Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells. Arch Biochem Biophys 332(2):295\u2013304. https:\/\/doi.org\/10.1006\/abbi.1996.0345","journal-title":"Arch Biochem Biophys"},{"key":"4185_CR48","first-page":"47","volume":"50","author":"J Schneider","year":"2012","unstructured":"Schneider J, Tsegaye Y, WT M et al (2012) Veno-occlusive liver disease: a case report. Ethiop Med J 50:47\u201351","journal-title":"Ethiop Med J"},{"issue":"2","key":"4185_CR49","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-4827(84)90581-0","volume":"150","author":"JB Schvartzman","year":"1984","unstructured":"Schvartzman JB, Krimer DB, Van\u2019t Hof J (1984) The effects of different thymidine concentrations on DNA replication in pea-root cells synchronized by a protracted 5-fluorodeoxyuridine treatment. Exp Cell Res 150(2):379\u2013389. https:\/\/doi.org\/10.1016\/0014-4827(84)90581-0","journal-title":"Exp Cell Res"},{"key":"4185_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/b978-0-12-380888-2.00003-0","volume":"108","author":"J Smith","year":"2010","unstructured":"Smith J, Tho LM, Xu N, Gillespie DA (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 108:73\u2013112. https:\/\/doi.org\/10.1016\/b978-0-12-380888-2.00003-0","journal-title":"Adv Cancer Res"},{"key":"4185_CR51","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2020.3","volume":"22","author":"HL Smith","year":"2020","unstructured":"Smith HL, Southgate H, Tweddle DA, Curtin NJ (2020) DNA damage checkpoint kinases in cancer. Expert Rev Mol Med 22:e2. https:\/\/doi.org\/10.1017\/erm.2020.3","journal-title":"Expert Rev Mol Med"},{"issue":"7","key":"4185_CR52","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1083\/jcb.200906064","volume":"187","author":"S So","year":"2009","unstructured":"So S, Davis AJ, Chen DJ (2009) Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites. J Cell Biol 187(7):977\u2013990. https:\/\/doi.org\/10.1083\/jcb.200906064","journal-title":"J Cell Biol"},{"issue":"5","key":"4185_CR53","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.3892\/ol.2018.9406","volume":"16","author":"R Song","year":"2018","unstructured":"Song R, Hou G, Yang J et al (2018) Effects of PLK1 on proliferation, invasion and metastasis of gastric cancer cells through epithelial-mesenchymal transition. Oncol Lett 16(5):5739\u20135744. https:\/\/doi.org\/10.3892\/ol.2018.9406","journal-title":"Oncol Lett"},{"issue":"1","key":"4185_CR54","first-page":"95","volume":"8","author":"BL Stegelmeier","year":"1999","unstructured":"Stegelmeier BL, Edgar JA, Colegate SM et al (1999) Pyrrolizidine alkaloid plants, metabolism and toxicity. J NatToxins 8(1):95\u2013116","journal-title":"J NatToxins"},{"key":"4185_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8120356","author":"BL Stegelmeier","year":"2016","unstructured":"Stegelmeier BL, Colegate SM, Brown AW (2016) Dehydropyrrolizidine alkaloid toxicity, cytotoxicity, and carcinogenicity. Toxins. https:\/\/doi.org\/10.3390\/toxins8120356","journal-title":"Toxins"},{"issue":"2","key":"4185_CR56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0016-5085(19)32224-3","volume":"73","author":"AS Stillman","year":"1977","unstructured":"Stillman AS, Huxtable R, Consroe P, Kohnen P, Smith S (1977) Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona. Gastroenterology 73(2):349\u2013352","journal-title":"Gastroenterology"},{"issue":"2","key":"4185_CR57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/toxins16020079","volume":"16","author":"B T\u00e1buas","year":"2024","unstructured":"T\u00e1buas B, Cruz Barros S, Diogo C, Cavaleiro C, Sanches Silva A (2024) Pyrrolizidine alkaloids in foods, herbal drugs, and food supplements: chemistry, metabolism, toxicological significance, analytical methods, occurrence, and challenges for future. Toxins 16(2):79","journal-title":"Toxins"},{"issue":"6","key":"4185_CR58","first-page":"607","volume":"70","author":"HD Tandon","year":"1978","unstructured":"Tandon HD, Tandon BN, Mattocks AR (1978) An epidemic of veno-occlusive disease of the liver in Afghanistan. Pathologic features. Am J Gastroenterol 70(6):607\u2013613","journal-title":"Am J Gastroenterol"},{"key":"4185_CR59","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2021","unstructured":"R Core Team (2021) R: A Language and Environment for Statistical Computing. Austria, Vienna"},{"issue":"1","key":"4185_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1165\/ajrcmb.19.1.2895","volume":"19","author":"HC Thomas","year":"1998","unstructured":"Thomas HC, Lam\u00e9 MW, Morin D, Wilson DW, Segall HJ (1998) Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 19(1):129\u2013142. https:\/\/doi.org\/10.1165\/ajrcmb.19.1.2895","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"4185_CR61","doi-asserted-by":"publisher","first-page":"12852","DOI":"10.1038\/ncomms12852","volume":"7","author":"F Treindl","year":"2016","unstructured":"Treindl F, Ruprecht B, Beiter Y et al (2016) A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun 7(1):12852. https:\/\/doi.org\/10.1038\/ncomms12852","journal-title":"Nat Commun"},{"key":"4185_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.fct.2018.02.036","volume":"114","author":"J Waizenegger","year":"2018","unstructured":"Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S (2018) Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: single versus repeated exposure. Food Chem Toxicol 114:215\u2013226. https:\/\/doi.org\/10.1016\/j.fct.2018.02.036","journal-title":"Food Chem Toxicol"},{"key":"4185_CR63","volume-title":"WHO IPCS International Programme on Chemical Safety: Pyrrolizidine alkaloids Environmental Health Criteria","author":"WHO","year":"1988","unstructured":"WHO (1988) WHO IPCS International Programme on Chemical Safety: Pyrrolizidine alkaloids Environmental Health Criteria, vol 80. World Health Organization, Geneva"},{"key":"4185_CR64","volume-title":"Pyrrolizidine Alkaloids","author":"H Wiedenfeld","year":"2008","unstructured":"Wiedenfeld H, R\u00f6der E, Bourauel T, Edgar J (2008) Pyrrolizidine Alkaloids. V&R Unipress, Bonn, Germany"},{"issue":"5069","key":"4185_CR65","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(01)00020-4","volume":"196","author":"FC Willmot","year":"1920","unstructured":"Willmot FC, Robertson GW (1920) Senecio disease, or cirrhosis of the liver due to senecio poisoning. Lancet 196(5069):848\u2013849. https:\/\/doi.org\/10.1016\/S0140-6736(01)00020-4","journal-title":"Lancet"},{"issue":"2","key":"4185_CR66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1006\/taap.2000.8966","volume":"166","author":"DW Wilson","year":"2000","unstructured":"Wilson DW, Lam\u00e9 MW, Dunston SK, Segall HJ (2000) DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells. Toxicol Appl Pharmacol 166(2):69\u201380. https:\/\/doi.org\/10.1006\/taap.2000.8966","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"4185_CR67","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13238-010-0010-5","volume":"1","author":"J Wu","year":"2010","unstructured":"Wu J, Lu LY, Yu X (2010) The role of BRCA1 in DNA damage response. Protein Cell 1(2):117\u2013123. https:\/\/doi.org\/10.1007\/s13238-010-0010-5","journal-title":"Protein Cell"},{"issue":"8","key":"4185_CR68","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/sj.onc.1208309","volume":"24","author":"Z Xiao","year":"2005","unstructured":"Xiao Z, Xue J, Sowin TJ, Rosenberg SH, Zhang H (2005) A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation. Oncogene 24(8):1403\u20131411. https:\/\/doi.org\/10.1038\/sj.onc.1208309","journal-title":"Oncogene"},{"key":"4185_CR69","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.redox.2017.02.020","volume":"12","author":"X Yang","year":"2017","unstructured":"Yang X, Wang H, Ni HM et al (2017) Inhibition of Drp1 protects against senecionine-induced mitochondria-mediated apoptosis in primary hepatocytes and in mice. Redox Biol 12:264\u2013273. https:\/\/doi.org\/10.1016\/j.redox.2017.02.020","journal-title":"Redox Biol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04185-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04185-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04185-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:39:44Z","timestamp":1760711984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04185-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4185"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04185-y","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}